Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2006

View Archived Issues

T-817MA protects neurons by activated PKC epsilon

BrainCells to find new CNS applications for Organon compounds

Orexo and Doxa collaborate on drugs with unique delivery technology

NOV-002 for ARS procurement no longer considered by HHS

Cardio Vascu-Grow studied in peripheral artery disease

ABT-279: Abbott's new selective and safe DPP-IV inhibitor

Sun Pharma's lead antiallergic molecule begins phase II in the U.S.

Amylin to study neurohormones used in combination to treat obesity

Preclinical advance for ChronVac-C administered using MedPulser delivery system

Positive preclinical data for Ampligen combined with H5N1 vaccine

Apadenoson begins phase Ib study

Enrollment placed on hold in phase IIb/III study of desmoteplase for stroke

Topical local anesthetic 1207 begins clinical testing

MKC-1 studied in combination with pemetrexed for NSCLC

TNX-650 studied for asthma in phase I

Pharmos closes acquisition of Vela Pharmaceuticals

New data support use of Xience V stent in diabetic patients

New phase I/II trial studies MGC-D0103 in combination with Gemzar

Japanese approval for Sonazoid ultrasound contrast medium

IS-811: selective CCR3 antagonist with potential in asthma therapy

Novel antiarthritic agents recently patented

Novel P2Y12 receptor antagonists emerge from Pfizer R&D

Recent patents disclose novel diagnostic agents

Preclinical studies show neuroprotective properties of ONO-2231 in animal models

Junovan filed for treatment of osteosarcoma

Gene variants linked to prostate cancer risk in African Americans

SSR-180711 could ameliorate negative symptoms of schizophrenia

Suven presents preclinical data on novel promising 5-HT6 receptor antagonists

Minocycline studied in clinical trial for multiple sclerosis / News in Context

Several large trials presented at International Society of Hypertension Meeting: Part I